ICYMI: G20 and World Health Assembly leaders support efforts to defeat COVID-19
While the COVID-19 pandemic continues to have an unprecedented impact on the health of communities and global economies, government leaders at the G20 and World Health Assembly discussed various approaches to controlling the spread of COVID-19 through science-based solutions.
IP20+ Virtual Forum Underscores Importance of Intellectual Property in Ending Pandemic
Saudi Arabia recently hosted the IP20+ Global Intellectual Property Challenges forum, bringing together the World Intellectual Property Organization (WIPO) and leaders of intellectual property (IP) offices across G20 countries to establish priorities in response to the COVID-19 pandemic and future emergencies.
What They Are Saying: Intellectual Property and Collaboration Critical to Combat COVID-19 in MENA
The biopharmaceutical industry relies on strong intellectual property (IP) rights and global collaboration to ensure the ongoing development of new treatments and cures for patients. Innovation, underpinned by reliable IP protections and strategic partnerships, is now more important than ever as researchers work around the clock to develop solutions to help prevent infection and treat patients with COVID-19, a disease caused by the novel strain of coronavirus.
A Closer Look at Intellectual Property and the COVID-19 Response
The 73rd World Health Assembly recently highlighted the global response to the COVID-19 pandemic, with all stakeholders working together to find solutions. It’s important to remember that intellectual property (IP) protections foster a robust innovation ecosystem and allow biopharmaceutical innovators to develop therapies and vaccines for patients in the MENA region and around the globe.